⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

IQV

IQVIA Holdings Inc.

Healthcare · Diagnostics & Research

256.98USD

-2.2300 (-0.86%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
1)

Comparable Revenue

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY14.4B15.0B15.4B16.3B17.4B18.5B
Q13.6B3.7B3.7B3.8B4.2B—
Q23.5B3.7B3.8B4.0B——
Q33.6B3.7B3.9B4.1B4.4B—
Q43.7B*3.9B*4.0B*4.4B*4.5B—
2)

Comparable Earnings Per Share

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY5.727.297.497.8412.9714.46
Q11.681.531.561.401.61—
Q21.341.591.971.54——
Q31.491.631.551.933.27—
Q41.19*

Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.

2.52*
2.38*
2.96*
3.65
—